STEVEN P HEDDINGER (MD) – Hematology & Oncology Physician, NPI 1750344743
Hematology & Oncology Physician
Main info
Doctor Profile
Contacts
Profile Insights
NPPES metrics only — not quality of care.
73 MEDICAL ONCOLOGY in IA
Provider Addresses for STEVEN P HEDDINGER (MD)
210 4th Ave
Grinnell, IA 501121898
Phone: (515) 282-2921
Fax: (515) 282-1035
Type: Location
12495 University Ave Ste 200
Clive, IA 503258290
Phone: (515) 282-2921
Fax: (515) 282-1035
Type: Location
1950 SW Magazine Rd
Ankeny, IA 500232977
Phone: (515) 282-2921
Fax: (515) 282-1035
Type: Location
110 E Court Ave Ste 200
Des Moines, IA 503092044
Phone: (515) 282-2921
Fax: (515) 282-1035
Type: Location
1221 PLEASANT ST STE 100
DES MOINES, IA 503091424
Phone: (515) 282-2921
Type: Location
200 HAWKINS DR
IOWA CITY, IA 522421009
Phone:
Type: Mailing
411 LAUREL ST STE A300
DES MOINES, IA 503143030
Phone: (515) 282-2921
Fax: (515) 282-1035
Type: Location
KKSO-AM (Des Moines), Fairview Drive, Pleasant Hill, Polk County, Iowa, 50327, United States
SUITE 100
DES MOINES, IA 50309
Phone:
Type: Mailing
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 60 Open Payments records for all available years, with a total value of $1,109.
Total Amount is formed as General ($1,109) + Research ($0) + Ownership ($0) = $1,109.
Last reported payment date: 2024-12-23 • Largest payer in this snapshot: Novartis Pharmaceuticals Corporation ($93).
Total Amount
$1,109
General + Research + Ownership
Payments
60
Total payment records
General Amount
$1,109
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-23
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| Novartis Pharmaceuticals Corporation | $93 |
| AstraZeneca Pharmaceuticals LP | $44 |
| Amgen Inc. | $39 |
| Celgene Corporation | $36 |
| PFIZER INC. | $36 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2006-02-21
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20060221000761 | I | Medical Oncology | IA | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 10,600 | 24 | $0 |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 7,650 | 11 | $0 |
| J0897 | Injection, denosumab, 1 mg | 6,540 | 33 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 5,608 | 15 | $0 |
| J0185 | Injection, aprepitant, 1 mg | 5,200 | 21 | $0 |
Insurance plans in this area (ZIP 50112)
Loading plans...
Provider's Procedures
| Specialty | Practice State | HCPCS Code | Description | Service Count | Beneficiary Count |
|---|---|---|---|---|---|
| MEDICAL ONCOLOGY | IA | 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | 409 | 66 |
| MEDICAL ONCOLOGY | IA | 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 112 | 26 |
Group practice members
| Name | Specialty | State |
|---|---|---|
| - | IA | |
| - | IA | |
| - | IA | |
| - | CA | |
| O P H T H A L M O L O G Y | IA | |
| - | IA | |
| - | IA | |
| - | IA | |
| - | CA | |
| - | IA |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.